Brief: IMCD To Acquire YCAM's Life Science Business In South Korea
Dec 18 (Reuters) - IMCD NV IMCD.AS :
* IMCD TO ACQUIRE THE LIFE SCIENCE BUSINESS OF YCAM IN SOUTH
KOREA
AND EXPAND ITS FOOTPRINT IN THE BEAUTY AND PERSONAL CARE MARKETS
* TRANSACTION EXPECTED TO CLOSE IN Q2 2025
* YCAM GENERATED REVENUE OF KRW 26 BILLION IN 2023
Source text: ID:nGNE8R3RbW
Further company coverage: IMCD.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))